Sanofi Competitors and Similar CompaniesClear all
Sanofi's competitors and similar companies include Viatris, AstraZeneca, Lilly, AbbVie, Pfizer, Novartis, Merck and Teva Pharmaceuticals.
 Sanofi Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions. |  Viatris Viatris is a pharmaceutical company that develops and manufactures branded and generic medicines, biosimilar medicines, and over-the-counter products. |  AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. |  Lilly Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products. |  AbbVie AbbVie is a pharmaceutical company engaged in the research, development, manufacturing, commercialization, and sale of medicines and therapies. |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  Merck Merck & Co (also known as Merck Sharp & Dohme) is a healthcare manufacturer and distributor of pharmaceuticals. | ||
Founding Date | Founding Date 2004 | Founding Date 2020 | Founding Date 1999 | Founding Date 1876 | Founding Date 2013 | Founding Date 1849 | Founding Date 1996 | Founding Date 1891 | Founding Date 1901 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||||||
Locations | Locations Canonsburg, US HQ Carole Park, AU Millers Point, AU Campos Dos Goytacazes, BR São Paulo, BR Sofia, BG Toronto, CA see more | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | Locations Indianapolis, US HQ Buenos Aires, AR Sydney, AU Wien, AT Brussel, BE São Paulo, BR Toronto, CA see more | Locations North Chicago, US HQ Alger, DZ Buenos Aires, AR Mascot, AU Wien, AT Wavre, BE Sarajevo, BA see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Bentley, AU Footscray, AU Mulgrave, AU Sydney, AU see more | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Rahway, US HQ Hydra, DZ Munro, AR Macquarie Park, AU Krems An Der Donau, AT Wien, AT Bruxelles, BE see more | Locations Petah Tikva, IL HQ Villa Adelina, AR Macquarie Park, AU Minsk, BY Antwerpen, BE Sao Paulo, BR Dupnica, BG see more | |
Employees | Employees 86,088 | Employees 38,0003% increase | Employees 89,900 | Employees 43,00010% increase | Employees 50,000 | Employees 88,0006% increase | Employees 76,057 | Employees 72,0007% increase | Employees 37,000 |
Valuation ($) | Valuation ($) 141.1 b | Valuation ($) 14 b | Valuation ($) 2.7 b | Valuation ($) 903.4 b | Valuation ($) 335 b | Valuation ($) 163.9 b | Valuation ($) N/A | Valuation ($) 294.7 b | Valuation ($) 20.8 b |
Financial | |||||||||
Revenue (est.) | Revenue (est.) €46.1b (FY, 2024) | Revenue (est.) $14.7b (FY, 2024) | Revenue (est.) $54.1b (FY, 2024) | Revenue (est.) $45b (FY, 2024) | Revenue (est.) $56.3b (FY, 2024) | Revenue (est.) $63.6b (FY, 2024) | Revenue (est.) $51.7b (FY, 2024) | Revenue (est.) $64.2b (FY, 2024) | Revenue (est.) $16.5b (FY, 2024) |
Cost of goods | Cost of goods €11.3b (FY, 2024) | Cost of goods $9.1b (FY, 2024) | Cost of goods $9b (FY, 2024) | Cost of goods $8.4b (FY, 2024) | Cost of goods $16.9b (FY, 2024) | Cost of goods $17.9b (FY, 2024) | Cost of goods $7.7b (FY, 2024) | Cost of goods $15.2b (FY, 2024) | Cost of goods $8.5b (FY, 2024) |
Gross profit | Gross profit €38.9b (FY, 2024) | Gross profit $5.6b (FY, 2024) | Gross profit $45.4b (FY, 2024) | Gross profit $36.6b (FY, 2024) | Gross profit $39.4b (FY, 2024) | Gross profit $45.8b (FY, 2024) | Gross profit $45.2b (FY, 2024) | Gross profit $49b (FY, 2024) | Gross profit $8.1b (FY, 2024) |
Net income | Net income €5.6b (FY, 2024) | Net income ($634.2m) (FY, 2024) | Net income $7b (FY, 2024) | Net income $10.6b (FY, 2024) | Net income $4.3b (FY, 2024) | Net income $8.1b (FY, 2024) | Net income $11.9b (FY, 2024) | Net income $17.1b (FY, 2024) | Net income ($2b) (FY, 2024) |
Operating ⚠ | |||||||||
Countries | Countries N/A | Countries 165 (Q1, 2023) | Countries 130 (FY, 2021) | Countries 120 (FY, 2021) | Countries 70 (FY, 2022) | Countries 125 (FY, 2021) | Countries N/A | Countries N/A | Countries N/A |
Manufacturing Sites | Manufacturing Sites N/A | Manufacturing Sites 40 (Q1, 2023) | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites 39 (FY, 2021) | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites N/A |
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products 27 (FY, 2019) | Phase I Trials Products N/A | Phase I Trials Products 27 (FY, 2021) | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products 8 (FY, 2021) | Phase II Trials Products N/A | Phase II Trials Products 25 (FY, 2021) | Phase II Trials Products N/A | Phase II Trials Products 85 (FY, 2022) | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 10 (FY, 2021) | Phase III Trials Products N/A | Phase III Trials Products 27 (FY, 2021) | Phase III Trials Products 44 (FY, 2022) | Phase III Trials Products 32 (FY, 2022) | Phase III Trials Products N/A |
Product Categories | Product Categories N/A | Product Categories 3 (Q1, 2023) | Product Categories N/A | Product Categories N/A | Product Categories 6 (FY, 2022) | Product Categories N/A | Product Categories N/A | Product Categories N/A | Product Categories N/A |
Projects in R&D Pipeline | Projects in R&D Pipeline 91 (FY, 2019) | Projects in R&D Pipeline N/A | Projects in R&D Pipeline 177 (FY, 2021) | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A |
Registration Phase Products | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products 10 (FY, 2021) | Registration Phase Products 8 (FY, 2022) | Registration Phase Products N/A | Registration Phase Products N/A |
Funding | |||||||||
Total funding raised | Total funding raised $ 310m | Total funding raised N/A | Total funding raised $ 1b | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 6.5m | Total funding raised N/A | Total funding raised $ 358m |
For sources of this data, please see the company profile
View Company Profiles
Viatris
HQ
Canonsburg, US
Employees
38,000↑ 3% increase
Viatris is a pharmaceutical company that develops and manufactures branded and generic medicines, biosimilar medicines, and over-the-counter products.
View companyAstraZeneca
HQ
Cambridge, GB
Employees
89,900
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View companyLilly
HQ
Indianapolis, US
Employees
43,000↑ 10% increase
Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products.
View companyAbbVie
HQ
North Chicago, US
Employees
50,000
AbbVie is a pharmaceutical company engaged in the research, development, manufacturing, commercialization, and sale of medicines and therapies.
View company